Pharmacovigilance in Cameroon: Past, Present and Future Developments in Unlocking the Drug Development Process

References (28)

1. 1 Adverse drug reactions: definitions, diagnosis, and management [DOI]
2. 2 Under-Reporting of Adverse Drug Reactions [DOI]
3. 3 Thalidomide‐induced teratogenesis: History and mechanisms [DOI]
4. 4 Clinically relevant drug interactions with antiepileptic drugs [DOI]
5. 5 Proposal for a New Tool to Evaluate Drug Interaction Cases [DOI]
6. 6 Impact of poor-quality medicines in the ‘developing’ world [DOI]
7. 7 The Gell–Coombs classification of hypersensitivity reactions: a re-interpretation [DOI]
8. 8 Pharmacovigilance in resource-limited countries [DOI]
9. 9 Pharmacovigilance: An Overview [DOI]
10. 10 Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase® [DOI]
11. 11 Medicines Regulation in Africa: Current State and Opportunities [DOI]
12. 12 Estimated Under-Five Deaths Associated with Poor-Quality Antimalarials in Sub-Saharan Africa [DOI]
13. 13 Under-reporting of adverse drug reactions: A challenge for pharmacovigilance in India [DOI]
14. 14 Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process [DOI]
15. 15 A Review of Pharmacovigilance [DOI]
16. 16 Spurious and counterfeit drugs: a growing industry in the developing world [DOI]
17. 17 Pharmacovigilance in perspective: drug withdrawals, data mining and policy implications [DOI]
18. 18 Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project [DOI]
19. 19 Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim®) in the treatment of uncomplicated malaria at public health facilities in four African countries [DOI]
20. 20 A national approach to pharmacovigilance: The case of India as a growing hub of global clinical trials [DOI]
21. 21 Pharmacovigilance and global HIV/AIDS [DOI]
22. 22 A situational analysis of pharmacovigilance plans in the Global Fund Malaria and U.S. President's Malaria Initiative proposals [DOI]
23. 23 Future Directions of Pharmacovigilance Studies Using Electronic Medical Recording and Human Genetic Databases [DOI]
24. 24 Fundamental concepts and terminology [DOI]
25. 25 Matching safety to access: global actors and pharmacogovernance in Kenya- a case study [DOI]
26. 26 Development of antimalaria, antibacterial, anticancer and antitumour drugs from new chemical entities from plant sources [DOI]
27. 27 Pharmacovigilance in developing countries [DOI]
28. 28 Active Safety Surveillance in Africa: Pragmatism and Agility [DOI]

Cited by 5

Showing 2 of 5 known citations — external sources report more than can currently be individually listed.

Related research

• Development or Adaptation of Clinical Guidelines in the Health System of Developing Countries: A Review Article — shares topic coverage
• Development of Pumpkin Pudding-like Food Using Soybeans [Glycine max (L.) Merr.] — shares topic coverage
• Development of a High Value Nutritious Baking Flour from Dried Ripe Banana Peels — shares topic coverage
• A Renewed Understanding of Shell-shape Diversity among Marine Gastropod Species: Invariance and Covariance between Geometrical Parameters in Conispirally Coiled Shells — shares topic coverage
• Growth and Development of Groundnut (Arachis hypogaea L.) as Influenced by Different Levels and Timing of Phosphogypsum Nutrition — shares topic coverage